Alcon ALC
NYSE ALC
$66.55 -1.88 (-2.75%)
As of: Sep 10, 2026 · 3:59 PM EDT

Alcon (ALC) Liabilities and Shareholders Equity (2009 - 2026)

Alcon (ALC) posted Liabilities and Shareholders Equity of $31.1 billion for Q2 2026, down 1.65% on a QoQ basis from $31.6 billion in Q1 2026, and down 0.92% year-over-year from $31.4 billion in Q2 2025.

Analysis

Alcon (ALC) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Alcon has reported Liabilities and Shareholders Equity for 11 years, with the latest figure at $31.1 billion in Q2 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 0.92% year-over-year to $31.1 billion in Q2 2026; TTM through Jun 2026 was $125.8 billion, a 36.59% increase from a year earlier, with the FY2025 full-year figure at $31.6 billion, up 3.98% from the prior year.
  • Liabilities and Shareholders Equity was $31.1 billion for Q2 2026 at Alcon, down from $31.6 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $31.6 billion in Q1 2026, with the low at $27.7 billion in Q2 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $29.8 billion, with a median of $29.6 billion recorded in 2023.
  • The sharpest annual moves came in 2023 and 2026: Liabilities and Shareholders Equity advanced 5.66% in 2023, then dropped 0.92% in 2026.
  • Over 5 years, Liabilities and Shareholders Equity stood at $29.2 billion in 2022, then grew by 1.54% to $29.6 billion in 2023, then grew by 2.48% to $30.3 billion in 2024, then rose by 3.98% to $31.6 billion in 2025, then dropped by 1.45% to $31.1 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $31.1 billion (Q2 2026), $31.6 billion (Q1 2026), and $31.6 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 109.22 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 20.88 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 93.31 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 47.93 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 13.87 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 31.10 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 6.46 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 10.74 Bn
10 Zimmer Biomet Holdings 17.73 Bn 17.32 Bn 1.54 Bn 22.80 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.10 Bn
Mar 31, 2026 31.62 Bn
Dec 31, 2025 31.56 Bn
Sep 30, 2025 31.52 Bn
Jun 30, 2025 31.39 Bn
Dec 31, 2024 30.35 Bn
Sep 30, 2024 30.36 Bn
Jun 30, 2024 29.72 Bn
Mar 31, 2024 29.57 Bn
Dec 31, 2023 29.61 Bn
Sep 30, 2023 29.37 Bn
Jun 30, 2023 29.21 Bn
Mar 31, 2023 29.29 Bn
Dec 31, 2022 29.17 Bn
Sep 30, 2022 27.80 Bn
Jun 30, 2022 27.73 Bn
Mar 31, 2022 27.79 Bn
Dec 31, 2021 28.00 Bn
Sep 30, 2021 27.80 Bn
Jun 30, 2021 27.75 Bn